McCall Appointed Vice Chair of Translational Research

Dr. Shannon J. McCall,  Vice Chair of Translational Research

I am very pleased to announce that Dr. Shannon J. McCall, Associate Professor, has been appointed Vice Chair of Translational Research in the Department of Pathology.  In this role, Dr. McCall will continue to facilitate extra-departmental research involving clinical tissue and fluid samples from Duke patients and enable expanded translational research by Department of Pathology faculty.
 
Dr. McCall is a thought leader in biospecimen science and data sharing who serves on national and international committees supporting quality in centralized bioresources.  As Vice Chair of Translational Research, Dr. McCall will continue to direct the BioRepository & Precision Pathology Center, serve as the Principal Investigator for the Southern Division of the National Cancer Institute (NCI)’s Cooperative Human Tissue Network (CHTN), co-direct Duke’s Precision Cancer Medicine Initiative, lead Duke’s participation in the American Association for Cancer Research’s genomic data sharing project, and direct the Pathology Study Program for Third Year Medical Students.  All these activities support expanded research opportunities for Pathology faculty and facilitate School of Medicine research involving Duke patient clinical tissue and fluid samples.
 
Specific responsibilities of the new Vice Chair of Translational Research role include broadening Pathology faculty access to the resources of the BioRepository & Precision Pathology Center (BRPC) and Precision Cancer Medicine Initiative, working with the Vice Chair of Laboratory Information Systems to ensure that faculty can easily identify translational research biospecimen cohorts, working with the Vice Chair of Anatomic Pathology and the Business Office to ensure that the clinical faculty compensation and support model encourages translational research, and working with the Medical Director of the Pathology Clinical Research Unit to ensure that all translational research with identifiable biospecimens follows Duke Office of Clinical Research and Institutional Review Board policies.
 
Please join me in congratulating Dr. McCall on her new role in expanding translational research for our department.
 

Jiaoti Huang, MD, Ph.D.
Chairman, Department of Pathology